Last reviewed · How we verify

LEGALON

Nhat Nhat Pharmaceutical Company · FDA-approved active Small molecule Quality 6/100

LEGALON is a Small molecule drug developed by Nhat Nhat Pharmaceutical Company. It is currently FDA-approved. Also known as: Silymarin.

At a glance

Generic nameLEGALON
Also known asSilymarin
SponsorNhat Nhat Pharmaceutical Company
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about LEGALON

What is LEGALON?

LEGALON is a Small molecule drug developed by Nhat Nhat Pharmaceutical Company.

Who makes LEGALON?

LEGALON is developed and marketed by Nhat Nhat Pharmaceutical Company (see full Nhat Nhat Pharmaceutical Company pipeline at /company/nhat-nhat-pharmaceutical-company).

Is LEGALON also known as anything else?

LEGALON is also known as Silymarin.

What development phase is LEGALON in?

LEGALON is FDA-approved (marketed).

Related